Next Generation Sequencing Market is Aims for USD 43.42 Billion and Rising Exponentially at Rate of 20.3% During the Forecast Period 2032 | Key Players- Eurofins GATC Biotech GmbH,Genomatix GmbH,Illumina Inc.

The next generation sequencing market size was valued at USD 8.24 billion in 2023. The next generation sequencing industry is projected to grow to USD 43.42 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 20.3% during the forecast period (2024 - 2032).

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧:

The technique known as "next generation sequencing" (NGS) examines genetic variation in illnesses and other biological phenomena by using DNA or RNA sequences. Because it made it possible to sequence several DNA strands simultaneously rather than one at a time, as is the case with standard Sanger sequencing by capillary electrophoresis, this technique was previously known as "massively parallel sequencing."

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐀 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐓𝐨 𝐆𝐚𝐢𝐧 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

• The expanding use of NGS in clinical diagnostics, cancer, reproductive health, and infectious disease management is driving the next-generation sequencing market forward.
• The increasing usage of next-generation sequencing technology in research and clinical applications is also influencing future demand and market prognosis.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

The industry is marked by fierce competition, and the leading companies rely on cutting-edge technology, superior goods, and a strong brand identity to boost sales. Here is the list of the leading companies operating in the next generation sequencing market:

• BGI
• Bio-Rad Laboratories, Inc.
• DNASTAR, Inc.
• Eurofins GATC Biotech GmbH
• Genomatix GmbH
• Illumina Inc.
• Invitae Corporation
• Oxford Nanopore Technologies
• Perkin Elmer, Inc.
• PierianDx
• Qiagen
• Roche Ltd.
• Thermo Fisher Scientific Inc.

𝐂𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐁𝐞𝐥𝐨𝐰 𝐋𝐢𝐧𝐤 𝐭𝐨 𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/buy/84/2

𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea, Australia)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐍𝐞𝐱𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 (𝐍𝐆𝐒) 𝐌𝐚𝐫𝐤𝐞𝐭

1. Increased Adoption in Clinical Diagnostics:
• Precision Medicine: The growing emphasis on precision medicine is leading to the increased use of NGS in clinical diagnostics. NGS enables the identification of specific genetic mutations, allowing for tailored treatment plans.
• Cancer Genomics: NGS is becoming a cornerstone in cancer diagnostics and treatment. It helps in identifying genetic mutations and alterations, leading to the development of targeted therapies and personalized treatment plans.

2. Technological Advancements:
• Improved Sequencing Platforms: Ongoing innovations in sequencing technologies are making NGS faster, more accurate, and cost-effective. These advancements include the development of third-generation sequencing technologies, which offer longer read lengths and higher throughput.
• Integration with AI and Machine Learning: The integration of artificial intelligence (AI) and machine learning (ML) with NGS data analysis is enhancing the interpretation of complex genomic data, leading to more accurate and actionable insights.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

The next generation sequencing market analysis is mainly based on the application, technology, product, end-use, and region. Based on the application analysis, in 2023, the diagnostics/infectious diseases segment led the market, owing to advances in liquid biopsies for cancer diagnosis and the global spread of COVID-19.

Furthermore, according to the product study, the instruments segment held the biggest market share during the projected period. It provides accurate and trustworthy genetic information in clinical diagnosis and illness treatment, indicating a high need for modern sequencing equipment. Continuous technological improvements have led to the creation of high-throughput sequencing technologies, which enable faster and more efficient DNA and RNA sequencing.

𝐍𝐞𝐱𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The reagents and consumables segment held the largest revenue share in the next-generation sequencing market due to an evolution in molecular genetics and an increase in demand for products and kits that accomplish size selection, target enrichment, and DNA fragmentation.

• The services segment witnessed the fastest market growth during the forecast period, owing to the improvement in the technology based on SMRT sequencing and a surge in the application of cloud computing for NGS data storage.

• In 2022, North America accounted for the largest market share owing to technological advancements in sequencing platforms and the surge in NGS applications in the region. The active support from the government and the surging prevalence of cancer will also drive the market's growth.

• Asia Pacific region witnessed the fastest growth in the next generation sequencing market. Due to the increasing investments in China and India in research and development of next generation sequencing.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞-𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏𝐌𝐑'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Tumor Ablation Market: https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market

Drug Discovery Informatics Market: https://www.polarismarketresearch.com/industry-analysis/drug-discovery-informatics-market

Xerostomia Therapeutics Market: https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market

Anesthesia Devices Market: https://www.polarismarketresearch.com/industry-analysis/global-anesthesia-devices-Market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.